The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Meropenem 2 g powder for solution for injection/infusion

Hikma Farmacêutica (Portugal) S.A.PA1217/006/003

Main Information

Trade NameMeropenem 2 g powder for solution for injection/infusion
Active SubstancesMeropenem Trihydrate
Dosage FormPowder for solution for injection/infusion
Licence HolderHikma Farmacêutica (Portugal) S.A.
Licence NumberPA1217/006/003

Group Information

ATC CodeJ01DH02 meropenem


License statusAuthorised
Licence Issued18/11/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back